Frequency of Xerostomia and Their Management in Upper Aerodigestive Tract Cancer Patients After the End of Radiotherapy

Assessment of Frequency of Xerostomia and Their Care Management in Upper Aerodigestive Tract Cancer Patients After the End of Radiotherapy

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02857413

Acronym

XEROSTOMIA

Enrollment

Registered

2016-08-05

Start date

2016-01-31

Completion date

2016-07-31

Last updated

2016-08-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Head and Neck Neoplasms

Keywords

Xerostomia, Radiotherapy

Brief summary

The aim of this study is the evaluation of the frequency of xerostomia and their management after radiotherapy in head and neck cancer. The quality of life of these patients is also analysed with European Organization for Research and Treatment of Cancer Quality of life Questionnaire H&N35 (EORTC QLQ H&N35).

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* patient with head and neck cancer after radiotherapy treatment

Exclusion criteria

* patient already treated for xerostomia for other reason : Sjögren's syndrome, medication, diabetes,...

Design outcomes

Primary

Measure	Time frame	Description
Frequency of xerostomia and their management after radiotherapy in head and neck cancer	at enrollment	patients describe the severity of their xerostomia and their management in a standardized questionnaire

Secondary

Measure	Time frame	Description
quality of life af patients after radiotherapy in head and neck cancer	at enrollment	patients describe their quality of life in a standardized questionnaire

Countries

France

Outcome results